Guoguang Ying

7.6k total citations · 3 hit papers
88 papers, 5.1k citations indexed

About

Guoguang Ying is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Guoguang Ying has authored 88 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 36 papers in Cancer Research and 22 papers in Oncology. Recurrent topics in Guoguang Ying's work include MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (13 papers) and Extracellular vesicles in disease (11 papers). Guoguang Ying is often cited by papers focused on MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (13 papers) and Extracellular vesicles in disease (11 papers). Guoguang Ying collaborates with scholars based in China, United States and Hong Kong. Guoguang Ying's co-authors include Haiyang Zhang, Ting Deng, Yi Ba, Haiou Yang, Jialu Li, Tao Ning, Shaohua Ge, Tao Ning, Xinyi Wang and Ming Bai and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Guoguang Ying

87 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer

2020 776 citations Haiyang Zhang, Ting Deng et al. profile →
Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis

2017 450 citations Haiyang Zhang, Ting Deng et al. Nature Communications profile →
Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer

2020 412 citations Haiyang Zhang, Haiou Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guoguang Ying China	36	4.0k	2.7k	759	692	590	88	5.1k
Fangyu Zhao China	42	3.7k 0.9×	2.8k 1.0×	1.3k 1.7×	633 0.9×	571 1.0×	124	5.5k
Amaia Lujambio United States	27	4.2k 1.0×	2.8k 1.0×	1.2k 1.6×	631 0.9×	764 1.3×	54	6.1k
Hongping Xia China	37	3.2k 0.8×	2.4k 0.9×	683 0.9×	604 0.9×	327 0.6×	97	4.5k
Florian A. Karreth United States	25	4.7k 1.2×	2.9k 1.1×	879 1.2×	343 0.5×	372 0.6×	53	5.9k
Rongcheng Luo China	35	2.4k 0.6×	1.3k 0.5×	1.1k 1.4×	686 1.0×	502 0.9×	207	4.2k
Jinjun Li China	45	4.8k 1.2×	3.1k 1.2×	1.7k 2.2×	553 0.8×	520 0.9×	137	7.0k
Yanyan Tang China	36	3.0k 0.8×	2.5k 0.9×	656 0.9×	400 0.6×	669 1.1×	78	4.3k
Qiuhui Pan China	31	4.3k 1.1×	3.1k 1.1×	898 1.2×	1.5k 2.1×	343 0.6×	66	5.7k
Chang Gong China	31	4.4k 1.1×	3.7k 1.4×	1.7k 2.2×	398 0.6×	649 1.1×	78	6.2k

Countries citing papers authored by Guoguang Ying

Since Specialization

Citations

This map shows the geographic impact of Guoguang Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoguang Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoguang Ying more than expected).

Fields of papers citing papers by Guoguang Ying

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoguang Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoguang Ying. The network helps show where Guoguang Ying may publish in the future.

Co-authorship network of co-authors of Guoguang Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Guoguang Ying. A scholar is included among the top collaborators of Guoguang Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoguang Ying. Guoguang Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiu, Lihua, Lijing Xing, Bo Sun, et al.. (2025). Prognostic value of lymphocyte subsets in diffuse large B cell lymphoma. Frontiers in Oncology. 15. 1671062–1671062.

Pan, Boyu, Zhu Han, Jiaqi Yang, et al.. (2024). From complexity to clarity: development of CHM-FIEFP for predicting effective components in Chinese herbal formulas by using big data. Cancer Biology and Medicine. 21(11). 1–11. 4 indexed citations

Li, Shuang, Jialu Li, Haiyang Zhang, et al.. (2021). Gastric cancer derived exosomes mediate the delivery of circRNA to promote angiogenesis by targeting miR-29a/VEGF axis in endothelial cells. Biochemical and Biophysical Research Communications. 560. 37–44. 51 indexed citations

Yang, Ronghui, Guoguang Ying, & Binghui Li. (2021). Potential of electron transfer and its application in dictating routes of biochemical processes associated with metabolic reprogramming. Frontiers of Medicine. 15(5). 679–692. 6 indexed citations

Ge, Shaohua, Haiyang Zhang, Ting Deng, et al.. (2019). MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer. Investigational New Drugs. 37(5). 923–934. 12 indexed citations

Wang, Xinyi, Haiyang Zhang, Haiou Yang, et al.. (2018). Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy. Current Cancer Drug Targets. 18(4). 347–354. 45 indexed citations

Liu, Miao, Yuan‐Yuan Wang, Changsen Bai, et al.. (2018). PKM2 promotes reductive glutamine metabolism. Cancer Biology and Medicine. 15(4). 389–389. 21 indexed citations

Ning, Tao, Haiyang Zhang, Xinyi Wang, et al.. (2017). miR-370 regulates cell proliferation and migration by targeting EGFR in gastric cancer. Oncology Reports. 38(1). 384–392. 22 indexed citations

Zhang, Haiyang, Ting Deng, Rui Liu, et al.. (2017). Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nature Communications. 8(1). 15016–15016. 450 indexed citations breakdown →

10.

Pan, Xing, Yuanyuan Wang, Miao Liu, et al.. (2017). NADPH accumulation is responsible for apoptosis in breast cancer cells induced by fatty acid synthase inhibition. Oncotarget. 8(20). 32576–32585. 28 indexed citations

11.

Deng, Jingyu, Han Liang, Guoguang Ying, et al.. (2014). Clinical Significance of the Methylated Cytosine-Phosphate-Guanine Sites of Protocadherin-10 Promoter for Evaluating the Prognosis of Gastric Cancer. Journal of the American College of Surgeons. 219(5). 904–913. 19 indexed citations

12.

Zuo, Duo, Liu R, Yanjie He, et al.. (2014). Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer. British Journal of Cancer. 111(10). 1965–1976. 77 indexed citations

13.

Ding, Ting, Minghao Yin, Kai Sun, et al.. (2013). Knockdown a Water Channel Protein, Aquaporin-4, Induced Glioblastoma Cell Apoptosis. PLoS ONE. 8(8). e66751–e66751. 39 indexed citations

14.

Yu, Qi, Guoguang Ying, Shuling Wang, et al.. (2013). Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER−, PR−, AR+ breast cancer. International Journal of Oncology. 44(1). 229–237. 33 indexed citations

15.

Duan, Lei, Srikumar M. Raja, Gengsheng Chen, et al.. (2010). Negative Regulation of EGFR-Vav2 Signaling Axis by Cbl Ubiquitin Ligase Controls EGF Receptor-mediated Epithelial Cell Adherens Junction Dynamics and Cell Migration. Journal of Biological Chemistry. 286(1). 620–633. 35 indexed citations

16.

Chen, Keqiang, Yingying Le, Ying Liu, et al.. (2010). Cutting Edge: A Critical Role for the G Protein-Coupled Receptor mFPR2 in Airway Inflammation and Immune Responses. The Journal of Immunology. 184(7). 3331–3335. 108 indexed citations

17.

Liu, Ying, Jingna Wang, Min Wu, et al.. (2009). Down-Regulation of 3-Phosphoinositide–Dependent Protein Kinase-1 Levels Inhibits Migration and Experimental Metastasis of Human Breast Cancer Cells. Molecular Cancer Research. 7(6). 944–954. 57 indexed citations

18.

Wu, Jing, Baogang Zhang, Min Wu, et al.. (2009). Screening of a PKC ζ-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis. Investigational New Drugs. 28(3). 268–275. 24 indexed citations

19.

Ying, Guoguang. (2009). Small Interfering RNA targeting PDK1 Inhibits Breast Cancer Cell Line Invasion and Metastasis. Clinical Oncology and Cancer Research. 1 indexed citations

20.

Ying, Guoguang, Pablo Iribarren, Ye Zhou, et al.. (2004). Humanin, a Newly Identified Neuroprotective Factor, Uses the G Protein-Coupled Formylpeptide Receptor-Like-1 as a Functional Receptor. The Journal of Immunology. 172(11). 7078–7085. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact